Zika Virus and Blood Safety

doi:10.3969/j.issn.1671-2587.2024.06.024

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2024, Vol. 26 ›› Issue (6): 859-864.DOI: 10.3969/j.issn.1671-2587.2024.06.024

Zika Virus and Blood Safety

WANG Yilai, CHEN Qingkai, HAN Guowei, HE Ziyi

Dongguan Blood Center, Dongguan 523000

Received:2024-01-30 Online:2024-12-20 Published:2024-12-20

Abstract

Abstract: In recent years, the Zika virus has broken out in many places around the world, and there is also a trend of local epidemic in China, which not only poses a serious threat to public health, but also to blood safety. The paper summarises the current status of ZIKV prevalence at home and abroad, routes of transmission, laboratory tests, potential risks of transmission through blood transfusion and strategies for transfusion transmission prevention.

Key words: Zika virus, Blood safety, Mosquito-borne transmission, Asymptomatic infection, Pathogen reduction technology

CLC Number:

R373

WANG Yilai, CHEN Qingkai, HAN Guowei, HE Ziyi. Zika Virus and Blood Safety[J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(6): 859-864.

References

[1] POSTLER T S,BEER M,BLITVICH B J,et al.Renaming of the genus Flavivirus to Orthoflavivirus and extension of binomial species names within the family Flaviviridae[J].Arch Virol,2023,168(9):224.
[2] HADDOW A D,SCHUH A J,YASUDA C Y,et al.Genetic characterization of Zika virus strains:geographic expansion of the Asian lineage[J].PLoS Negl Trop Dis,2012,6(2):e1477.
[3] BERNARDO-MENEZES L C,AGRELLI A,OLIVEIRA A S L E,et al.An overview of Zika virus genotypes and their infectivity[J].Rev Soc Bras Med Trop,2022,55:e02632022.
[4] DE MELO FREIRE C C,IAMARINO A,DE LIMA NETO D F,et al.Spread of the pandemic Zika virus lineage is associated with NS1 codon usage adaptation in humans[C].2015
[5] ATIF M,AZEEM M,SARWAR M R,et al.Zika virus disease:a current review of the literature[J].Infection,2016,44(6):695-705.
[6] GOURINAT A C,O'CONNOR O,CALVEZ E,et al. Detection of Zika virus in urine[J].Emerg Infect Dis,2015,21(1):84-86.
[7] OEHLER E,WATRIN L,LARRE P,et al.Zika virus infection complicated by Guillain-Barre syndrome—case report,French Polynesia,December 2013[J].Euro Surveill,2014,19(9):20720.
[8] BAUD D,GUBLER D J,SCHAUB B,et al.An update on Zika virus infection[J].Lancet,2017,390(10107):2099-2109.
[9] WHO.Zika Virus (ZIKV) classification table[EB/OL].[2024-1-21].http://apps.who.int/iris/bitstream/handle/10665/260419/zika-classification-15Feb18-eng.pdf?sequeence=1,2018-02-15.
[10] 李建华,黄仁发,杨健平,等.中国大陆首例输入性寨卡病毒感染病例临床表现及实验室检测结果分析[J].中国公共卫生,2016,32(4):413-415.
[11] HSIEH C J,WU W T,LIN M H,et al.Epidemiological characteristics of zika virus infections imported into Taiwan between 2016 and 2021[J].J Med Sci,2024.
[12] 王亚丽,张晓怡,任瑞琦,等.中国内地25例输入性寨卡病毒病病例流行病学与临床特征分析[J].中国媒介生物学及控制杂志,2017,28(6):535-537.
[13] 李多,曹继东,康家荣,等.云南省首例输入性寨卡病毒病病例流行病学调查及病原分子特征分析[J].中国病毒病杂志,2022,12(5):358-363.
[14] WEAVER S C,CHARLIER C,VASILAKIS N,et al.Zika,chikungunya,and other emerging vector-borne viral diseases[J].Annu Rev Med,2018,69:395-408.
[15] COUNOTTE M J,KIM C R,WANG J Y,et al.Sexual transmission of Zika virus and other flaviviruses:a living systematic review[J].PLoS Med,2018,15(7):e1002611.
[16] SPITERI G,SUDRE B,SEPTFONS A,et al.Surveillance of Zika virus infection in the EU/EEA,June 2015 to January 2017[J].Euro Surveill,2017,22(41): 17-00254.
[17] Prevention C F D C.Zika cases in the United States: cumulative Zika virus disease case counts in the United States,2015-2018[EB/OL].[2024-1-21].https://www.cdc.gov/zika/reporting/case-counts.html.
[18] BESNARD M,LASTèRE S,TEISSIER A,et al.Evidence of perinatal transmission of Zika virus,French Polynesia,December 2013 and February 2014[J].Euro Surveill,2014,19(13):20751.
[19] ODUYEBO T,PETERSEN E E,RASMUSSEN S A,et al.Update:interim guidelines for health care providers caring for pregnant women and women of reproductive age with possible zika virus exposure-United States,2016[J].MMWR Morb Mortal Wkly Rep,2016,65(5):122-127.
[20] LIU R F,WANG X Z,MA Y,et al.Prevalence of Zika virus in blood donations:a systematic review and meta-analysis[J].BMC Infect Dis,2019,19(1):590.
[21] MOTTA I J F,SPENCER B R,CORDEIRO DA SILVA S G,et al.Evidence for transmission of zika virus by platelet transfusion[J].N Engl J Med,2016,375(11):1101-1103.
[22] 慕容容,叶海艳,徐敏,等.寨卡病毒感染与输血安全[J].中国输血杂志,2021,34(4):424-427.
[23] KHONGWICHIT S,CHUCHAONA W,VONGPUNSAWAD S,et al.Molecular epidemiology,clinical analysis,and genetic characterization of Zika virus infections in Thailand (2020-2023)[J].Sci Rep,2023,13(1):21030.
[24] NOORBAKHSH F,ABDOLMOHAMMADI K,FATAHI Y,et al.Zika virus infection,basic and clinical aspects:a review article[J].Iran J Public Health,2019,48(1):20-31.
[25] WANG Z Y,WANG P G,AN J.Zika virus and Zika fever[J].Virol Sin,2016,31(2):103-109.
[26] MASMEJAN S,MUSSO D,VOUGA M,et al.Zika virus[J].Pathogens,2020,9(11):898.
[27] 贺梦娇,秦成峰,李晓峰.先天性寨卡综合征及其致病机制研究进展[J].科学通报,2021,66(31):3937-3943.
[28] 常嘉彤,盛子洋,王培刚.先天性非小头畸形寨卡病毒感染的研究进展[J].微生物学免疫学进展,2021,49(5):78-83.
[29] FILGUEIRAS I S,TORRENTES DE CARVALHO A,CUNHA D P,et al.The clinical spectrum and immunopathological mechanisms underlying ZIKV-induced neurological manifestations[J].PLoS Negl Trop Dis,2021,15(8):e0009575.
[30] HE Z J,AN S,CHEN J H,et al.Neural progenitor cell pyroptosis contributes to Zika virus-induced brain atrophy and represents a therapeutic target[J].Proc Natl Acad Sci USA,2020,117(38):23869-23878.
[31] ADAM A,LEE C,WANG T.Rational development of live-attenuated zika virus vaccines[J].Pathogens,2023,12(2):194.
[32] LOW S L,LEO Y S,LAI Y L,et al.Evaluation of eight commercial Zika virus IgM and IgG serology assays for diagnostics and research[J].PLoS One,2021,16(1):e0244601.
[33] HAYES E B.Zika virus outside Africa[J].Emerg Infect Dis,2009,15(9):1347-1350.
[34] CHAN K R,ISMAIL A A,THERGARAJAN G,et al.Serological cross-reactivity among common flaviviruses[J].Front Cell Infect Microbiol,2022,12:975398.
[35] STONE M,BAKKOUR S,LANTERI M C,et al.Zika virus RNA and IgM persistence in blood compartments and body fluids:a prospective observational study[J].Lancet Infect Dis,2020,20(12):1446-1456.
[36] 李阿茜,梁米芳,李建东,等.用于检测登革热,基孔肯雅及寨卡病毒的三重实时荧光定量PCR引物和探针及试剂盒[P].2022.
[37] 滕新栋,刘迪,杨宇,等.一种基于RAA技术的白纹伊蚊及携带寨卡病毒,基孔肯雅病毒和登革病毒同时检测试剂盒及检测方法[P].2023.
[38] LUM F M,LIN C,SUSOVA O Y,et al.A sensitive method for detecting zika virus antigen in patients' whole-blood specimens as an alternative diagnostic approach[J].J Infect Dis,2017,216(2):182-190.
[39] IOOS S,MALLET H P,LEPARC GOFFART I,et al.Current Zika virus epidemiology and recent epidemics[J].Med Mal Infect,2014,44(7):302-307.
[40] GIMéNEZ-RICHARTE á,ORTIZ DE SALAZAR M I,GIMéNEZ-RICHARTE M P,et al.Transfusion-transmitted arboviruses:update and systematic review[J].PLoS Negl Trop Dis,2022,16(10):e0010843.
[41] FAYE O,FAYE O,DIALLO D,et al.Quantitative real-time PCR detection of Zika virus and evaluation with field-caught mosquitoes[J].Virol J,2013,10:311.
[42] DUFFY M R,CHEN T H,HANCOCK W T,et al.Zika virus outbreak on Yap Island,Federated States of Micronesia[J].N Engl J Med,2009,360(24):2536-2543.
[43] PLOURDE A R,BLOCH E M.A literature review of zika virus[J].Emerg Infect Dis,2016,22(7):1185-1192.
[44] STONE M,LANTERI M C,BAKKOUR S,et al.Relative analytical sensitivity of donor nucleic acid amplification technology screening and diagnostic real-time polymerase chain reaction assays for detection of Zika virus RNA[J].Transfusion,2017,57(3pt2):734-747.
[45] SLAVOV S N,HESPANHOL M R,RODRIGUES E S,et al.Zika virus RNA detection in asymptomatic blood donors during an outbreak in the northeast region of So Paulo State,Brazil,2016[J].Transfusion,2017,57(12):2897-2901.
[46] GALLIAN P,CABIé A,RICHARD P,et al.Zika virus in asymptomatic blood donors in Martinique[J].Blood,2017,129(2):263-266.
[47] ZHENG X,ZENG J F,XU X X,et al.A preliminary survey of Zika virus infection by nucleic acid test in the volunteer blood donor samples in Shenzhen China[J].J Med Virol,2020,92(8):1326-1329.
[48] ZHOU C M,LIU J W,QI R,et al.Emergence of Zika virus infection in China[J].PLoS Negl Trop Dis,2020,14(5):e0008300.
[49] BENJAMIN R J.Zika virus in the blood supply[J].Blood,2017,129(2):144-145.
[50] 郭永建. 美国FDA《血液行业指引:降低寨卡病毒输血传播风险的推荐意见》主要内容及其启示[J].中国输血杂志,2016,29(2):227-230.
[51] PETERSEN L R,JAMIESON D J,POWERS A M,et al.Zika virus[J].N Engl J Med,2016,374(16):1552-1563.
[52] CHEVALIER M S,BIGGERSTAFF B J,BASAVARAJU S V,et al.Use of blood donor screening data to estimate zika virus incidence,Puerto Rico,april-august 2016[J].Emerg Infect Dis,2017,23(5):790-795.
[53] SAá P,PROCTOR M,FOSTER G,et al.Investigational testing for zika virus among U.S.blood donors[J].N Engl J Med,2018,378(19):1778-1788.
[54] GOODNOUGH L T,MARQUES M B.Zika virus and patient blood management[J].Anesth Analg,2017,124(1):282-289.
[55] LESSLER J,OTT C T,CARCELEN A C,et al.Times to key events in Zika virus infection and implications for blood donation:a systematic review[J].Bull World Health Organ,2016,94(11):841-849.
[56] FRYK J J,MARKS D C,HOBSON-PETERS J,et al.Reduction of Zika virus infectivity in platelet concentrates after treatment with ultraviolet C light and in plasma after treatment with methylene blue and visible light[J].Transfusion,2017,57(11):2677-2682.
[57] WANG Y C,REN K,LIAO X Z,et al.Inactivation of Zika virus in plasma and derivatives by four different methods[J].J Med Virol,2019,91(12):2059-2065.
[58] LAUGHHUNN A,SANTA MARIA F,BROULT J,et al.Amustaline (S-303) treatment inactivates high levels of Zika virus in red blood cell components[J].Transfusion,2017,57(3pt2):779-789.
[59] GIMéNEZ-RICHARTE á,ORTIZ DE SALAZAR M I,GIMéNEZ-RICHARTE M P,et al.Pathogen inactivation methods to prevent transfusion-transmissible arboviruses:a systematic review and meta-analysis[J].Trop Med Int Health,2023,28(4):262-274.

Zika Virus and Blood Safety

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 14

Recommended Articles

Metrics

Comments

About

Author

Journal

Access Statistics

Contact

[1]	YANG Jianhao, QIU Yingjie, ZHANG Shunwei, DU Yi, HU Tianyan, XU Bei. Evaluation of Screening Results of Positive Bacteria of Apheresis Platelets in Shanghai [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(4): 499-504.
[2]	LIU Hong, MO Qin, MA Rongna, JIA Yao, WU Xiaofei, WANG Xun. The Effects of Riboflavin Concentrations and Visible Light Intensities on E. Coli in Plasma [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(1): 29-34.
[3]	ZHAO Dongyan, SHEN Youhua, TIAN Zhibin, et al. Comparative Analysis of Causes of Deferred Blood Donation between Whole Blood and Aphaeresis Donors [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(3): 388-395.
[4]	CHENG Zhi-xiang, REN Lin, CAO Hong-rong, et al. Haemovigilance for Guideline-based Blood Transfusion Adverse Events [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(1): 48-55.
[5]	DAI Hua-you, LIU Kai-qiang, LIU Xiao-jie, et al. Analysis of Haemovigilance of Adverse Events in Blood Establishments from 2020 to 2021 [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(1): 56-62.
[6]	YAN Jun, YIN Wen, ZHANG Kan. Impact of SARS-CoV-2 on Blood Safety [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(3): 232-235.
[7]	WANG Xiang-ping, GUO Jian-bo, DUAN Rong, et al. Analysis of Screening Results by Nucleic Acid Test in Voluntary Blood Donors in Hengyang [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2018, 20(6): 563-565.
[8]	LIN Jun-tian, LIU Zhi-hua, HE Qi-tong, et al. Analysis of Enzyme Immunoassay Combined with Detection of Nucleic Acid Technology among Voluntary Blood Donors in Foshan [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2018, 20(6): 569-571.
[9]	LIU Hong-mei，LU Zhi-hao.. Analysis of Syphilis Tests in Unpaid Blood Donors of Fuyang City [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2018, 20(3): 259-260.
[10]	WANG Yuan-jie，LIU Jia-rui，Li Hong-mei，et al.. Several Problems Should be Paid Attention to in the Application of Electronic Blood Cross Matching [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2018, 20(3): 308-311.
[11]	LI Peng, GUO Yi. Detection and Analysis of Human Parvovirus B19 Antigens and Antibodies in Methylene Blue Inactivated Virus-free Plasma [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2018, 20(1): 20-22.
[12]	JI Rong-rong, ZHANG Xi-min, Kang-Na. A Preliminary Analysis of Abnormal Color of Donated Plasma [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2017, 19(6): 553-555.
[13]	HOU Yun, FENG Qiu-xia, YANG Zhong-si, et al. An Appropriate Pre-donation Screening Mode in Low-risk Fixed Blood Donors [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2017, 19(3): 284-288.
[14]	HUANG Hui, CHEN Xiu-lan, WU Jie, et al. Analysis of Blood Concentration Detection in Southern Anhui [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2017, 19(3): 291-294.